Market By Application, Modality And Country | Forecast 2019-2028
Triton Market Research’s report on the Latin American extra corporeal membrane oxygenation (ECMO) system market depicts that it will proliferate at a CAGR of 4.55% in terms of revenue, during the forecasted period 2019-2028.
Report scope can be customized per your requirements. Request For Customization
The countries reviewed in the Latin American extra corporeal membrane oxygenation (ECMO) system market are:
• Mexico
• Brazil
• Rest of Latin America
As per the WHO, in 2018, coronary heart disease-related deaths in Brazil were about 1 million. The rising incidence of this disease is likely to boost the demand for extracorporeal membrane oxygenation (ECMO) system in the country. Besides, there are growing government awareness programs regarding the benefits of ECMO. This is expected to drive the overall growth of the ECMO system market in the country. The ECMO market in Mexico is accelerating at a considerable growth rate due to biomass smoke exposure, smoking and the growing prevalence of heart diseases. Also, the growing COPD is anticipated to boost the extracorporeal membrane oxygenation system market in Mexico.
In Argentina, heart attack remains one of the leading causes of death, estimating a broad patient base for ECMO. The first neonatal or pediatric extracorporeal membrane oxygenation program in the region was established in Chile in 2003. All these factors are likely to boost the market growth.
Abbott Laboratories is a pharmaceutical company involved in the development of the manufacturing and marketing of different healthcare products. The company provides neuromodulation devices, diagnostic systems, medical devices, nutritional products for pediatric & adult patients. Some of its brands are Oxepa, Similac, Cell-Dyn, Heptral, Duspatal, and FreeStyle. The company offers its products to consumers, retailers, wholesalers, healthcare facilities and government agencies. The CentriMag Acute Circulatory Support System is a technology provided by the company, designed to offer excellent hemocompatibility.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT
1. LATIN AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1.MARKET DEFINITION
2.2.PORTER’S FIVE FORCES MODEL
2.2.1.THREAT OF NEW ENTRANTS
2.2.2.THREAT OF SUBSTITUTE PRODUCTS
2.2.3.BARGAINING POWER OF BUYERS
2.2.4.BARGAINING POWER OF SUPPLIERS
2.2.5.COMPETITIVE RIVALRY
2.3.IMPACT OF COVID-19 ON ECMO SYSTEM MARKET
2.4.MARKET ATTRACTIVENESS INDEX
2.5.VENDOR SCORECARD
2.6.KEY INSIGHTS
2.7.MARKET DRIVERS
2.7.1.RISING POPULARITY OF ECMO TECHNOLOGY
2.7.2.INCREASING PREVALENCE OF CHRONIC DISORDERS
2.8.MARKET RESTRAINTS
2.8.1.SIGNIFICANT COST OF ECMO SYSTEMS
2.8.2.EXISTENCE OF ALTERNATIVE TECHNIQUES
2.9.MARKET OPPORTUNITIES
2.9.1.GROWING AWARENESS REGARDING APPLICATIONS OF ECMO SYSTEMS
2.9.2.ADVANCEMENT IN TECHNOLOGY
2.10.MARKET CHALLENGES
2.10.1.LACK OF SPECIALIZED SKILLS FOR OPERATION
2.10.2.RISKS ASSOCIATED WITH ECMO PROCEDURES
3. EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET OUTLOOK - BY APPLICATION
3.1.RESPIRATORY
3.2.CARDIAC
3.3.EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR)
4. EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET OUTLOOK - BY MODALITY
4.1.VENO-VENOUS
4.2.VENO-ARTERIAL
4.3.OTHER MODALITIES
5. EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET – LATIN AMERICA
5.1.BRAZIL
5.2.MEXICO
5.3.REST OF LATIN AMERICA
6. COMPANY PROFILES
6.1.HEMOVENT GMBH
6.2.LIVANOVA PLC
6.3.MICROPORT SCIENTIFIC CORPORATION
6.4.TERUMO MEDICAL CORPORATION
6.5.ELSIUS BIOMEDICAL INC
6.6.ABBOTT LABORATORIES
6.7.ALUNG TECHNOLOGIES INC
6.8.EUROSETS
6.9.SPECTRUM MEDICAL
6.10.XENIOS AG (FRESENIUS SE & CO KGAA)
6.11.MEDTRONIC PLC
6.12.GETINGE AB
6.13.NIPRO CORPORATION
6.14.ORIGEN BIOMEDICAL INC
7. RESEARCH METHODOLOGY & SCOPE
7.1.RESEARCH SCOPE & DELIVERABLES
7.1.1.OBJECTIVES OF STUDY
7.1.2.SCOPE OF STUDY
7.2.SOURCES OF DATA
7.2.1.PRIMARY DATA SOURCES
7.2.2.SECONDARY DATA SOURCES
7.3.RESEARCH METHODOLOGY
7.3.1.EVALUATION OF PROPOSED MARKET
7.3.2.IDENTIFICATION OF DATA SOURCES
7.3.3.ASSESSMENT OF MARKET DETERMINANTS
7.3.4.DATA COLLECTION
7.3.5.DATA VALIDATION & ANALYSIS
TABLE 1 LATIN AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, 2019-2028 ($ MILLION)
TABLE 2 VENDOR SCORECARD
TABLE 3 LATIN AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY APPLICATION, 2019-2028 ($ MILLION)
TABLE 4 LATIN AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY MODALITY, 2019-2028 ($ MILLION)
TABLE 5 LATIN AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, 2019-2028 ($ MILLION)
FIGURE 1 LATIN AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)
FIGURE 2 LIST OF CHRONIC DISEASES
FIGURE 3 LATIN AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY RESPIRATORY, 2019-2028 ($ MILLION)
FIGURE 4 LATIN AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY CARDIAC, 2019-2028 ($ MILLION)
FIGURE 5 LATIN AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR), 2019-2028 ($ MILLION)
FIGURE 6 LATIN AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY VENO-VENOUS, 2019-2028 ($ MILLION)
FIGURE 7 LATIN AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY VENO-ARTERIAL, 2019-2028 ($ MILLION)
FIGURE 8 LATIN AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY OTHER MODALITIES, 2019-2028 ($ MILLION)
FIGURE 9 BRAZIL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)
FIGURE 10 MEXICO EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)
FIGURE 11 REST OF LATIN AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)